Federico Paoletti-Paolini

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Cerebrospinal fluid and plasma biomarkers in idiopathic normal pressure hydrocephalus: comparison with Alzheimer's and Parkinson's diseases.

Cerebrospinal fluid and plasma biomarkers in idiopathic normal pressure hydrocephalus: comparison with Alzheimer's and Parkinson's diseases.

Journal: Frontiers in aging neuroscience

Published: April 26, 2026

α-Synuclein Seed Amplification Assays: High Promise, Real-World Variability, and an Urgent Need for Standardization.

α-Synuclein Seed Amplification Assays: High Promise, Real-World Variability, and an Urgent Need for Standardization.

Journal: Neurology

Published: January 28, 2026

Caregiver burden of parkinsonian patients with impulse control disorders, depression and apathy.

Caregiver burden of parkinsonian patients with impulse control disorders, depression and apathy.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: January 09, 2026

Blood-based biomarkers for Alzheimer's disease: influence of kidney function.

Blood-based biomarkers for Alzheimer's disease: influence of kidney function.

Journal: Alzheimer's research & therapy

Published: November 01, 2025

Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease.

Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease.

Journal: Neurobiology of disease

Published: September 15, 2025

Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease.

Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease.

Journal: Journal of Parkinson's disease

Published: May 23, 2025

Effect of aging on biomarkers and clinical profile in Parkinson's disease.

Effect of aging on biomarkers and clinical profile in Parkinson's disease.

Journal: Journal of neurology

Published: April 15, 2025

Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy.

Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy.

Journal: NPJ Parkinson's disease

Published: March 29, 2025

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.

Journal: Nature medicine

Published: March 21, 2025

Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease.

Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease.

Journal: Alzheimer's research & therapy

Published: February 26, 2025

Research advancement in fluid biomarkers for Parkinson's disease.

Research advancement in fluid biomarkers for Parkinson's disease.

Journal: Expert review of molecular diagnostics

Published: September 12, 2024

Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria.

Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria.

Journal: Journal of Alzheimer's disease : JAD

Published: April 12, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026